Angiotensin II-induced insulin resistance and protein tyrosine phosphatases

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 11, 2004, Pages 2009-2013

  Marrero, Mario B ^a   Fulton, David ^a   Stepp, David ^a   Stern, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiotensin II; Insulin resistance; PTB 1B

Indexed keywords

ANGIOTENSIN; INSULIN RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; RECEPTOR PROTEIN;

DEPHOSPHORYLATION; ENZYME PHOSPHORYLATION; INSULIN RESISTANCE; KIDNEY PARENCHYMA; MITOGENESIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SHORT SURVEY; SIGNAL TRANSDUCTION; VASCULAR TISSUE;

ANGIOTENSIN II; ANIMALS; HUMANS; INSULIN RESISTANCE; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 8344259035     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000140059.04717.f3     Document Type: Short Survey

References (37)

1. Ling BN. Regulation of mesangial chloride channels by insulin and glucose: role in diabetic nephropathy. Clin Exp Pharmacol Physiol. 1996; 23:89-94.
2. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy - An update. Hypertension. 1995;26:869-879.
3. Wautier JL, Guillausseau PJ. Diabetes, advanced glycation endproducts and vascular disease. Vasc Med. 1998;3:131-137.
4. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Ploverini PJ, Bouck NP. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest. 1996;98:671-679.
5. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med. 1996;334:1649-1654.
6. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol. 2004;286:H1597-H1602.
7. Bernstein KE, Marrero MB. The importance of tyrosine phosphorylation in angiotensin II signaling. Trends Cardiovasc Med. 1996;6:179-187.
8. Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB. Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose. Kidney Int. 2002;61:1605-1616.
9. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem. 1997;272:24684-24690.
10. Townsend RR. Angiotensin and Insulin resistance: conspiracy theory. Curr Hypertens Rep. 2003;5:110-116.
11. Avruch J. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem. 1998;182:31-48.
12. Darnell JE Jr. STATs and gene regulation. Science. 1997;277:1630-1635.
13. Fucini RV, Okada S, Pessin JE. Insulin-induced desensitization of extracellular signal-regulated kinase activation results from an inhibition of Raf activity independent of Ras activation and dissociation of the Grb2-SOS complex. J Biol Chem. 1999;274:18651-18658.
14. DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 1992;20:S1-S16.
15. Ueda S, Petrie JR, Cleland SJ, Elliott HL, Connell JMC. Insulin vasodilatation and the "arginine paradox". Lancet. 1998;351:959-960.
16. Kahn AM, Allen JC, Zhang S. Insulin increases NADH/NAD+ redox state, which stimulates guanylate cyclase in vascular smooth muscle. Am J Hypertens. 2002;15:273-279.
17. Ogihara T, Asano T, Ando K, Chiba Y, Sakoda H, Anai M, Shojima N, Ono H, Onishi Y, Fujishiro M, Katagiri H, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Komuro I, Fujita T. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension. 2002;40:872-879.
18. Rao RH. Effects of angiotensin II on insulin sensitivity and fasting glucose metabolism in rats. Am J Hypertens. 1994;7:655-660.
19. Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M. Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats. Hypertension. 2001;38:884-890.
20. Kudoh A, Matsuki A. Effects of Angiotensin-Converting Enzyme Inhibitors on Glucose Uptake. Hypertension. 2000;36:239-244.
21. Shaw SS, Schmidt AM, Banes AK, Wang XD, Stern DM, Marrero MB. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2. Diabetes. 2003;52:2381-2388.
22. Shaw S, Wang XD, Redd H, Alexander GD, Isales CM, Marrero MB. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem. 2003;278:30634-30641.
23. Fauman EB, Saper MA. Structure and function of the protein tyrosine phosphatases. Trends Biochem Sci. 1996;21:413-417.
24. Tonks NK, Neel BG. From form to function: signaling by protein tyrosine phosphatases. Cell. 1996;87:365-368.
25. Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC. Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2. Am J Physiol. 1998;275:C1216-C1223.
26. Marrero MB, Schieffer B, Paxton WG, Duff JL, Berk BC, Bernstein KE. The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling. Cardiovascular Res. 1995;30:530-536.
27. Wenzel UO, Fouqueray B, Biswas P, Grandaliano G, Choudhury GG, Abboud HE. Activation of mesangial cells by the phosphatase inhibitor vanadate: potential implications for diabetic nephropathy. J Clin Invest. 1995;95:1244-1252.
28. Asante-Appiah E, Kennedy BP. Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am J Phys-Endocrinol Metab. 2003;284:E663-E670.
29. Byon JC, Kusari AB, Kusari J. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Molecular and Cellular Biochemistry. 1998;182:101-108.
30. Virkamäki A, Ueki K, Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest. 1999;103:931-943.
31. Touyz RM, Tabet F, Schiffrin EL. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol. 2003;30:860-866.
32. Ali MS, Schieffer B, Delafontaine P, Bernstein KE, Ling BN, Marrero MB. Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells. J Biol Chem. 1997;272:12373-12379.
33. Marrero MB, Banes AK, Tawfik A, Shaw S. PPAR effects on the angiotensin II-induced insulin resistance in blood vessels. American Heart Association, Research Symposium, 76th Scientific Sessions. 2003.
34. Tao J, Malbon CC, Wang Hy. Insulin Stimulates Tyrosine Phosphorylation and Inactivation of Protein-tyrosine Phosphatase 1B in Vivo. J Biol Chem. 2001;276:29520-29525.
35. Dulin NO, Niu JX, Browning DD, Ye RD, Voyno-Yasenetskaya T. Cyclic AMP-independent activation of protein kinase A by vasoactive peptides. J Biol Chem. 2001;276:20827-20830.
36. Zhong HH, SuYang H, ErdjumentBromage H, Tempst P, Ghosh S. The transcriptional activity of NF-kappa B is regulated by the I kappa B-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 1997;89:413-424.
37. Digicaylioglu M, Lipton SA. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signalling cascades. Nature. 2001;412:641-647.